In short, liraglutide, GLP-1 receptor agonist, has a direct effect on atherosclerosis lesion formation via promoting pro-resolving M2 macrophages phenotype
Subsequently, the text is cleaned further by removing English stop words, punctuation, capitalization, special characters, and duplicate posts
If a primary driver is identified, it must be addressed before or in parallel with antioxidant support
While individual results vary based on personal health metrics, clinical data show that individuals using medical GLP-1 protocols lose an average of 15% to 20% of their total body weight when paired with positive lifestyle changes
Most patients will never experience this complication, but the possibility highlights the importance of medical supervision during treatment